{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:16:17Z","timestamp":1791778577044,"version":"4.3.4"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2006,1,18]]},"DOI":"10.1001\/jama.295.3.293","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T16:28:01Z","timestamp":1137515281000},"page":"293","source":"Crossref","is-referenced-by-count":546,"title":["Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa"],"prefix":"10.1001","volume":"295","author":[{"given":"Kathryn A.","family":"O\u2019Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/202213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T13:26:30Z","timestamp":1481808390000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.295.3.293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,18]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,1,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.295.3.293","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1087020.539986","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1,18]]}}}